Supplemental Table 3.docx (14.02 kB)

Supplemental Table 3. Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck squamous cell carcinoma

dataset

posted on 2021-05-28, 08:17 authored by Karthik Ramakrishnan, Zhiwen Liu, Shrujal Baxi, Sheenu Chandwani, Sam Joo, Diana Chirovsky

Supplemental Table 3. Real-world time on treatment among patients with R/M HNSCC with 1L platinum monotherapy

Funding

Merck

History

Usage metrics

Read the peer-reviewed publication

Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck squamous cell carcinoma

Future Oncology

Categories

Cancer therapy (excl. chemotherapy and radiation therapy)

Keywords

Head and neck squamous-cell carcinoma antineoplastic agents immunological antibodies Kaplan-Meier estimate patient outcomes real-world observational study treatment patterns Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0

Exports